.

What's Hot in Workers' Comp

TOP 10 DEVELOPMENTS IN DELAWARE WORKERS’ COMPENSATION IN 2024

What’s Hot in Workers’ Comp, Vol. 28, No. 12, December 2024

December 1, 2024

by Benjamin K. Durstein

1.    The Delaware Supreme Court affirmed an Industrial Accident Board decision that concluded that a COVID-19 workplace exposure at a poultry processing plant did not qualify as a compensable occupational disease.
Fowler v. Perdue, 320 A.3d 196 (Del. June 24, 2024)

Mr. Fowler alleged that he suffered a compensable COVID-19 exposure while working as a “boxer” at a poultry processing plant. The Industrial Accident Board determined the claimant met his burden to prove that he more likely than not contracted COVID-19 in the cafeteria at work. However, under the Air Mod and Anderson analyses, in order to qualify as a compensable occupational disease, a claimant must show the COVID-19 infection “resulted from the peculiar nature of Mr. Fowler’s employment,” meaning the job had “a hazard distinct from and greater than the hazard attending employment in general.” Mr. Fowler did not satisfy those requirements, and the petition was denied.

On appeal, the Delaware Superior Court further explained the evidence showed that the cafeteria at Perdue presented a greater hazard than that attending employment in general. However, the hazard was not distinct from that attending employment in general.

The Delaware Supreme Court followed that same line of reasoning and affirmed the decisions below. The court conceded the cafeteria at Perdue was a high-risk environment and that essential workers at the time were at a higher risk than the general population. However, the evidence to show that the hazard was distinct from employment in general was not sufficient. The claimant attempted to prove that COVID-19 was peculiar to the poultry factory work by referencing congressional reports showing the prevalence of COVID-19 in meat factories and the underreporting of meat industry companies when it came to COVID-19. The court noted the studies did not reference Perdue as a source for that data or explain what specifically about working in the meat industry caused COVID exposure, besides being in crowded places in close proximity, like many other jobs. The court rejected the claimant’s last argument that the Board ignored that the exposure could have happened in both the box room and the cafeteria at work. The decision was affirmed.

2.    The Superior Court affirmed an Industrial Accident Board decision that concluded a claimant injured while performing employer-related volunteer activity was not within the course and scope of employment.
Testa-Carr v. Sallie Mae, 2024 WL 510993 (Del. Super. Feb. 8, 2024)

Ms. Testa-Carr worked as a customer service representative for Sallie Mae. On March 21, 2022, while delivering Meals on Wheels to an apartment in Newark, she fell down a flight of stairs and was injured. This volunteer work was arranged via Sallie Mae’s Employee Volunteer Program (EVP). The injury occurred during work hours, and the claimant was paid PTO for the volunteer work pursuant to the EVP. The employer denied on the basis that the volunteer activity was not within the course and scope of her employment. Ms. Testa-Carr filed a petition with the Industrial Accident Board to get her work accident accepted.

After an evidentiary hearing, the Board determined the claimant failed to meet her burden to prove she was within the course and scope of her employment. The Board determined that the correct legal standard was the analysis for non-sponsored recreational activities. It reasoned the claimant failed to satisfy any of the three factors established by the Larson’s treatise under a totality of the circumstances.

On appeal, the claimant contended the Board incorrectly applied the second and third factors of the Larson’s test. Specifically, the claimant argued that (1) Sallie Mae impliedly made the volunteer activity part of the services of an employee, thus bringing it within the orbit or employment, and (2) Sallie Mae derived a substantial direct benefit from the EVP. 

The court agreed with the Board’s conclusions and rationales on both issues. According to the court, the Board emphasized that volunteering was optional, employees were not treated better or worse based on their decision to volunteer, and the employee had complete discretion about what volunteer activity he or she wished to perform. Moreover, while the employer derived some benefit from employees’ volunteerism, the claimant’s outing did not reach the level of “substantial direct benefit” required by the third Larson’s factor. Ms. Testa-Carr chose Meals on Wheels on her own, was not required or encouraged to wear Sallie Mae apparel or identification, was not required to communicate with the recipients of the meal, had performed this volunteer activity on her own in the past, and conceded she often did not see the recipients. The the court found the Board’s decision was supported by substantial evidence and affirmed.

3.    The Delaware Supreme Court affirmed decisions of the Industrial Accident Board and Superior Court which held that an employer correctly paid for ketamine infusion treatment in accordance with the Delaware Fee Schedule.
Taylor v. State of Delaware, 314 A.3d 1107, 2024 WL 1209292 (Del. March 21, 2024) (TABLE)

Ms. Taylor injured her right wrist in 2016 while working as a teacher for the State of Delaware. The injury developed into complex regional pain syndrome (CRPS), involving multiple extremities. From 2017 to 2021, the State paid for 23 ketamine-infusion treatments to treat Ms. Taylor’s CRPS condition rendered by an out-of-state provider, Fort Washington Surgery Center. In 2019, the State contracted with a new bill-review company that paid substantially lower amounts than was paid for the same treatment previously. Ms. Taylor filed a petition that alleged these lower payments were insufficient and inconsistent with Delaware law. The Industrial Accident Board and Superior Court determined the payments made by the State were correct under the Delaware Workers’ Compensation Act’s healthcare payment system and fee schedule. The Superior Court affirmed the decision. The claimant appealed to the Delaware Supreme Court.

On appeal, Ms. Taylor argued the Industrial Accident Board failed to correctly apply the Act and Fee Schedule regulations, as interpreted in a Superior Court opinion Delaware Veterans Home v. Dixon. Specifically, the claimant alleged the Industrial Accident Board failed to assess the adequacy of medical billing codes by referring to resources from the American Medical Association or the National Correct Coding Institute. The court rejected this argument, noting the claimant bore the burden of proof on whether the billing codes used by the provider for the ketamine infusion treatment were insufficient or inaccurate. The resources cited by the claimant, while referenced in the fee schedule administrative regulations, the claimant failed to present such evidence at the Industrial Accident Board hearing. Further, it was emphasized that neither the employer nor the Board are responsible to present that evidence. There was no legal error. 

The court further advised that the Act’s Oversight Panel is the proper forum to determine whether specific billing codes provide reasonable compensation for a particular treatment, which was a secondary argument advanced by the claimant. The decisions below were affirmed.

4.    The Supreme Court affirmed an Industrial Accident Board decision and rejected an employer’s arguments that Superior Court Civil Rule 41(a)(1) and the doctrine of collateral estoppel barred a claimant from filing a petition for a recurrence of total disability benefits.
United Parcel Service v. Hawkins, 314 A.3d 663, 2024 WL 666726 (Del. Feb. 19, 2024) (TABLE)

Mr. Hawkins was injured in a work accident on October 28, 2018. On December 9, 2019, the claimant filed a Petition to Determine Additional Compensation Due that sought total disability benefits (TTD) and two surgeries, including a spine surgery. The employer filed a Petition for Review to terminate TTD. The claimant withdrew the TTD petition without prejudice. The Petition for Review was resolved via a settlement of the parties. Per a stipulation of the parties, approved by the Industrial Accident Board, the claimant’s TTD was terminated as of February 7, 2020, and he was placed on temporary partial disability benefits (TPD) as of October 17, 2020.

On April 20, 2021, the claimant filed a Petition to Determine Additional Compensation Due that again sought acknowledgment of two spine surgeries, resulting periods of total disability beginning on January 10, 2022, and extending beyond the TPD agreement. Before the hearing, the claimant voluntarily withdrew the petition. The claimant re-filed an identical petition on December 10, 2021. The employer moved to dismiss the petition on multiple bases, including that it was barred by (1) the doctrine of collateral estoppel, (2) the doctrine of res judicata and (3) Superior Court Civil Rule 41(a)(1)’s “Two Dismissal” rule. 

The Board rejected the employer’s arguments regarding collateral estoppel and res judicata because the issues and claims presented by the Petition to Determine Additional Compensation Due were new and different from prior agreements between the parties. Additionally, the Board explained it is not bound by the Superior Court Rules of Civil Procedure. Its own rules, and the rules of the Administrative Procedures Act, do not include a similar provision. Accordingly, it did not regard the petition as dismissed with prejudice. The employer’s motion was denied. The Superior Court agreed with the Board’s conclusions.

The Supreme Court affirmed that the Industrial Accident Board is not required to follow the Superior Court Rules of Civil Procedure in its proceedings. Whether to rely on or to consider court rules is within the Board’s discretion. No provision of the Industrial Accident Board Rules, the Workers’ Compensation Act or the Administrative Procedures Act indicates otherwise.

Additionally, the court agreed with and expanded on the collateral estoppel rulings below. The court explained that a consent judgment—such as the Board-approved Read-In Order terminating TTD as of February 7, 2020—generally cannot support claims of issue preclusion. Collateral estoppel only applies when the facts have been “actually litigated and determined” in the first case. The stipulation did not clearly manifest the parties’ intention to be bound by the employer’s allegation that “claimant’s disability had terminated as of February 7, 2020.” Accordingly, collateral estoppel did not bar the claimant from bringing the claim for a recurrence of total disability.

5.    The Superior Court affirmed an Industrial Accident Board decision that denied  a claimant’s Motion to Strike medical expert testimony regarding medical records produced for the first time after the claimant’s medical expert deposition. 
Trincia v. Dick’s Sporting Goods, 2024 WL 1110401 (Del. Super. March 14, 2024)

Ms. Trincia filed a Petition to Determine Compensation Due that alleged she injured her cervical spine and left shoulder in a work accident on September 23, 2020. The claimant’s primary care physician, Dr. Ivins, did not produce medical records in response to a subpoena request by the employer until four days before the hearing—after the claimant’s medical expert had testified by deposition. The employer immediately produced the records to the claimant. The next day, the employer’s medical expert testified and addressed Dr. Ivins’ records. The claimant filed a Motion to Strike portions of the employer’s expert’s testimony that referenced the records or, alternatively, to continue the hearing and afford the claimant’s expert the opportunity to review the records and offer additional testimony.

The Industrial Accident Board denied the claimant’s motion, holding the employer reasonably obtained and timely produced the records. It was not the employer’s fault the claimant did not have the records. Moreover, the claimant could not be surprised by her own medical records. The Board conducted the hearing on the claimant’s petition and concluded she was not credible and failed to meet her evidentiary burden. The Board emphasized that the claimant continued to work her normal hours for two weeks after the accident and never reported the accident during that time. She then requested off the work schedule because she did not feel well and not because of the work injury. Further, the claimant’s initial medical records after the accident did not document a work accident but were subsequently changed by undated notes from the providers without explanation.

On appeal, the claimant contended that neither party was at fault for the delay in production of Dr. Ivins’ medical records and it was unfair and prejudicial to the claimant to allow the employer’s expert to review and testify regarding the records without affording the claimant’s expert the same opportunity. The claimant was not surprised the records existed but was surprised by the contents of those records. For those reasons, the claimant argued the Board’s ruling constituted an abuse of discretion.

The Superior Court confirmed that the production of the records was a violation of the rule that requires production of pertinent documents 30 days prior to a hearing but that the records were not obtained surreptitiously. The claimant should have been aware of her own medical records. It was up to the claimant, not the employer, to make sure she had the documents necessary for her expert and her case. 

Additionally, the Board explained its reasons for why it did not find the claimant to be credible and denied the petition. The evidentiary ruling was not an abuse of discretion and there was substantial evidence in the record to support the Board’s conclusions. The decision was affirmed.

6.    The Superior Court affirmed a decision of the Industrial Accident Board that enforced a workers’ compensation settlement agreement and rejected a claimant’s attorney’s argument he is entitled to a common law “attorney’s charging lien,” which was not a term of the settlement.
Webb v. State of Delaware, 2024 WL 2077263 (Del. Super. May 9, 2024)

Mr. Webb was injured and missed time from work as a result of that injury. However, his workers’ compensation claim was denied, so he filed a petition with the Industrial Accident Board that sought acknowledgment of the accident, medical expense benefits and temporary total disability (TTD) benefits. Mr. Webb received short term disability (STD) benefits from his employer for the time he missed from work. The STD benefits were provided at no cost to the claimant and wholly funded by the employer through the Insurance Coverage Office (ICO). 

The employer eventually acknowledged the work accident as compensable and agreed to pay medical expenses and TTD of $15,556.00. The settlement offer from the employer specified that the TTD period overlapped with the STD period and there was a likely offset as the claimant could not receive both. Accordingly, the TTD check was to be held in an escrow account until the ICO calculated the recoupment amount owed for the STD benefits that were paid during the TTD period. Additionally, there was no separate attorney fee payable as part of the settlement. The claimant accepted the offer. The TTD check was issued and delivered to the claimant’s attorney, again with the explicit requirement that the funds were subject to offset by the STD benefits paid and should not be disbursed until the correct recoupment amount was determined.

The ICO determined the STD recoupment owed was $15,486.00—almost equivalent to the TTD payment. Instead of reimbursing the ICO per the settlement agreement, the claimant’s attorney sent the TTD check back and demanded an “attorney’s lien” on the TTD amount paid for one-third of the total recovery, the private contingent fee negotiated between the claimant and his attorney. The employer filed a motion with the Industrial Accident Board to enforce the settlement agreement. The Board held the settlement contract was clear, the claimant was to repay the STD recoupment amount once it was determined and no separate attorney fee was included as part of the agreement. The claimant was ordered to issue the check to the ICO. The claimant appealed.

On appeal, the claimant’s attorney contended the Board did not have jurisdiction to enforce the settlement agreement and the workers’ compensation insurance carrier did not have a right to negotiate the STD recoupment. The court held that the Board had authority to adjudicate the ICO’s right to set off its payments against payments awarded by the workers’ compensation carrier. The Industrial Accident Board has statutory authority to give effect to agreements between the parties, including provisions not directly related to the compensation, itself. Moreover, the court held the Industrial Accident Board’s authority to award attorney fees was limited by statute. The claimant’s attorney’s private contingent fee with Mr. Webb did not create a right to the fee from the ICO. The court would not void and rewrite the agreement. The claimant’s attorney was not entitled to the relief requested. The Industrial Accident Board’s decision was affirmed.

7.    The Delaware Superior Court affirmed a decision of the Industrial Accident Board and rejected a claimant’s argument on appeal that the Board’s decision to allow certain questioning from the employer’s attorney constituted a reversible abuse of discretion.
Rosenblum v. City of Wilmington, 2024 WL 3876630 (Del. Super. August 20, 2024)

On July 19, 2017, Mr. Rosenblum injured his right shoulder while working for the Wilmington Police Department, resulting in surgery. After the right shoulder surgery, the claimant began to experience pain in his left shoulder. He believed this pain was caused by overuse because he was unable to use the right arm normally while he recovered from surgery. The employer denied the left shoulder problem was causally related to the work accident. The case went before the Industrial Accident Board.

The Board denied that the left shoulder injury was causally related to the work accident. The Board reasoned there were inconsistencies between the medical records and Mr. Rosenblum’s testimony, which undermined his credibility. Additionally, the Board concluded the opinions of the employer’s medical expert, Dr. Gelman, were more credible than the claimant’s expert. During the hearing, it was revealed that Mr. Rosenblum told his treating surgeon that the pain started far earlier than what was documented in the medical records. However, the decision was appealed because the claimant took issue with the Board’s reliance on discovery to find Mr. Rosenblum not credible.

Specifically, on appeal, the claimant’s attorney requested a reversal of the Board’s decision because the employer’s attorney had asked questions of Mr. Rosenblum during the hearing with reference to medical records and failed to produce the documents. The claimant argued the questions were more akin to statements made by the employer’s attorney that were unsupported and did not afford the claimant an opportunity to confirm the accuracy of the questions. The argument was that the questions and resultant testimony violated Delaware Rules of Evidence 612 and 613, which concern what documents need to be shown to a witness or attorney upon request. The employer argued there was no objection during the hearing, so the argument was waived for appeal. Moreover, even if some of the questioning was precluded, there was substantial evidence in the record, including the expert credibility determination to support the decision.

The Superior Court agreed that attorney statements are not testimony and that the information the Board heard in the questions was likely not admissible in Superior Court. However, Industrial Accident Board Rule 16(B) expressly permits the Board to disregard customary rules of evidence so long as it does not amount to an abuse of discretion. There was no abuse of discretion in this case, and there was competent testimony from the employer’s expert witness to support the decision to deny the claim. The appeal was denied.

8.    Workers’ compensation trends.

The Industrial Accident Board has repeatedly stressed the importance of employers completing and filing timely First Reports of Injury (FROI). Failure to do so can result in sanctions and delays in litigation. The Board will not move forward with petitions until it receives a completed FROI to document the work accident. The Workers’ Compensation Fund continues to be aggressive with reimbursement requests and scrutiny of continuance requests that result in increased Fund payments. There was dialogue from the Department of Labor regarding an exodus of providers from the workers’ compensation system. This is consistent with the statistics of the 2024 annual report referenced below, which reflect a significant decrease in certified providers. The expectation is that this trend will continue.

9.    New workers’ compensation rates.

The Department of Labor announced that the new workers’ compensation rates effective July 1, 2024, establish an average weekly wage of $1,328.01. Accordingly, the maximum weekly compensation rate is $885.34 and the minimum weekly compensation rate is $295.12.

10.    Statistics from the Department of Labor.

The 26th Annual Report from the Department of Labor is available on the State’s website and provides updates, data and information that cover the year 2023.

Of note, the average dispositional speed from the filing of a petition to the issuance of a decision was reduced for a third consecutive year, despite a deficit in Hearing Officer staffing. The overall reduction in time is 24% since 2020. Utilization Review requests decreased again, this time by 10% in 2023 compared to 2022. Approximately 78.75% of those requests resulted in an appeal to the Industrial Accident Board, which was an increase from 2022. Chronic pain treatment continues to represent the most challenged treatment modality. In 2023, there were 1,845 active certified providers in Delaware, which represented a 13.14% decrease from 2022. More petitions were filed for the first time since 2018, although the amount of hearings decreased slightly. There was a slight decrease in commutation settlements reviewed from the prior year. Five-year cumulative statistics on appeals indicates the Industrial Accident Board has rendered 1,375 decisions, 193 of which were appealed. Seventy-two decisions were affirmed, 22 were reversed or remanded, 82 were dismissed or withdrawn and 17 were pending decision at the time of the report. 


 

What’s Hot in Workers’ Comp, Vol. 28, No. 12, December 2024 is prepared by Marshall Dennehey to provide information on recent legal developments of interest to our readers. This publication is not intended to provide legal advice for a specific situation or to create an attorney-client relationship. We would be pleased to provide such legal assistance as you require on these and other subjects when called upon. ATTORNEY ADVERTISING pursuant to New York RPC 7.1 Copyright © 2023 Marshall Dennehey, all rights reserved. No part of this publication may be reprinted without the express written permission of our firm. For reprints or inquiries, or if you wish to be removed from this mailing list, contact tamontemuro@mdwcg.com.

 

Firm Highlights

Thought Leadership

Casual Care, Serious Consequences: How Informal Prescribing Can Trigger Medical Board Scrutiny

The lesson for health care practitioners is that regular review of the regulatory requirements can ensure compliance and that casual prescribing may be in violation of state regulations if the necessary components are not met. Consider the following scenario: in December 2025, a medical provider renewed a prescription for a long-standing telemedicine patient receiving a Schedule II controlled dangerous substance. This was not a violation of the New Jersey Administrative Code. Another provider doing the same action for an equally situated patient in March 2026 would be in violation. The casual prescriber who is not aware of newer regulatory requirements may have a more difficult time responding to a medical board complaint. Medicine is a highly-regulated helping profession. Without addressing the merits of this regulatory burden, the practice of medicine continues to see drastic changes impacting the everyday life of patient and provider. Telemedicine, COVID-19, and other advances and roadblocks, present a challenge to those saving lives while attempting to comply with the rules of practice. Physicians often discover—through real cases and the lens of regulatory expectations—that even well-intentioned informal help can be reinterpreted as stepping outside mandated professional boundaries, and seemingly harmless actions can be construed as deviations from required practice standards specifically outlined in Title 13, Chapter 35, Subchapters 7.1A of the New Jersey Administrative Code. Title 45, "Professions and Occupations," of the New Jersey code governs the practice of medicine, nursing, optometry, pharmacy, and many other professional occupations. Section 9 specifically addresses the state board of medical examiners and allows for the creation of rules and regulations in Section 45:9-5.3. These regulations can be found in the New Jersey Administrative Code Title 13, Chapter 35. While broad in scope, Chapter 35 contains a subchapter dedicated to the administration and dispensing of prescription drugs. Such knowledge will arm physicians with the tools they need to prevent a negative outcome if a medical board complaint is filed. Likewise, attorneys must be familiar with these regulatory requirements when advising and defending providers. In New Jersey, N.J.A.C. Section 13:35-7.1A(a) requires that a practitioner conduct an examination and appropriately document the same within the medical record before dispensing drugs or issuing prescriptions. The examination must include an "appropriate history and physical examination," a diagnosis based upon the examination and any testing consistent with good medical care, the formulation of a therapeutic plan discussed with the patient, and the availability of appropriate follow-up care. There are only six exceptions to this requirement: In admission orders for a newly hospitalized patient For a patient of another physician for whom the practitioner is taking calls For continuation medications on a short-term basis for a new patient prior to the patient's first appointment For an established patient who, based on sound medical practice, the physician believes does not require a new examination before issuing a new prescription For a patient examined by a healthcare professional who is in collaborative practice with the practitioner When treatment is provided by a practitioner for an emergency medical condition Emergencies are also limited to situations where someone's health is in serious jeopardy, there is serious impairment to bodily functions, or serious dysfunction of any bodily organ or part. During the COVID-19 pandemic, then New Jersey Governor Phil Murphy issued an executive order declaring a public health emergency and a state of emergency that allowed authorized prescribers to prescribe Schedule II controlled dangerous substances via telemedicine. The order was terminated when he left office earlier this year and the state reverted to the requirement of an initial in-person examination and quarterly in-person visits. With this return to prior regulatory requirements, practitioners subject to the jurisdiction of the board of medical examiners may benefit from a refresher on the regulatory limitations on their practice now that the pandemic-era flexibilities have ended. This new requirement may create confusion for prescribers and lead to casual prescribing of medication in violation of the regulations, even in the setting of recurrent telemedicine appointments as noted in the example above. Casual prescribing can take many forms: filling a prescription request from a friend or family member without an examination or contemporary medical record; using telemedicine to expand your practice without proper in-person appointments or documentation in the medical record; failing to ensure appropriate follow-up care for a "one time" prescription; etc. Although not all board complaints end in a publicly available opinion, serious deviations from regulatory requirements can shine a light on practices that will require action by the board if a complaint is received. Consider the following cases: In October 2025, the board issued a final consent order in an administrative action where a doctor provided opioids without examination and his license was permanently revoked. In re Robert Dela Gente, D.O., N.J. State Bd. of Med. Exam'rs Oct. 21, 2025. Criminal charges were filed (though that is not always the case). In a September 2025 consent order, a physician was reprimanded for "prescribing opioids several months in advance without the proper patient follow-up..." and explained that they did so for "patients who can not pay for multiple visits to refill medications." In re A/an E. Schultz, M.D., N.J. State Bd. of Med. Exam'rs Sept. 25, 2025. Another physician was suspended and placed on probation in a consent order for prescribing three patients the weight-loss medication "Ozempic" via text messages through a website called "Push Health" and without any further communication with the patients or taking a medical history. In re Laura E. Purdy, M.D., N.J. State Bd. of Med. Exam'rs Aug. 29, 2025. A June 2025 interim consent order required a "full evaluation and assessment of [a physician's] general knowledge and skill, with specific emphasis on his knowledge of and ability to safely prescribe [controlled dangerous substances]" due to his failure to review a patient's prior medical history and medical record, assess and review the prescription monitoring program before prescribing CDS, and conduct random urine screens on a patient that tested positive for CDS upon admission to his practice because "he trusted the patient." In re Donald Oh, M.D., N.J. State Bd. of Med. Exam'rs June 2, 2025. Each of these examples demonstrate a failure to follow strict procedure regardless of the intention. Failing to follow procedure secondary to good intentions, such as considering a patient's financial constraints, trust in the patient, or utilizing a new telemedicine service platform, will not be a defense to a board complaint. Especially when practicing via telemedicine, practitioners must ensure they are adhering to the appropriate regulatory standard. A provider who calls in a prescription for a traveling friend or family member or agrees to prescribe medication for individuals using the newest phone app will have a hard time meeting the requirements of N.J.A.C. Section 13:35-7.1A. Even if a history was taken, a "therapeutic plan" was created, and "follow up care" was provided, the prescriber would still not be in compliance with the regulation without an in-person examination. In our opening hypothetical, the prescriber's behavior did not change between December and March; however, the legal shift in the regulatory landscape made once acceptable behavior a violation as a required examination did not occur. When complaints are made with regard to informal prescribing, the board has discretion to employ measures to encourage compliance in lieu of formal proceedings such as a private, written warning; suspending fines subject to continuing compliance; medical or professional treatment as may be necessary; medical or diagnostic testing and monitoring; skills assessment; corrective training; participation in outreach programming; or contribution to the consumer fraud protection fund. The lesson for health care practitioners is that regular review of the regulatory requirements can ensure compliance and that casual prescribing may be in violation of state regulations if the necessary components are not met. Even compliant providers who had not conducted an in-person examination for telemedicine patients during the COVID-19 emergency would be in violation of the regulations as of January 2026 for the same practice. Practitioners should be diligent in adhering to the prescribing rules to avoid sanctions related to casual care. Likewise, attorneys advising or defending practitioners before the board must be aware of the in-person examination requirements for prescribing in New Jersey whether the care in question took place in-person or in a telemedicine setting. Reprinted with permission from the April 22, 2026 issue of the New Jersey Law Journal. ©2026 ALM Media Properties, LLC. Further duplication without permission is prohibited. All rights reserved.

Result

No-Cause Jury Verdict Secured in Wrongful Death Trial

We successfully obtained a no-cause jury verdict in a 13-day wrongful death trial. The decedent, a 59-year-old man, was admitted to the emergency room on February 15, 2019, with complaints of abdominal pain, decreased appetite, and constipation, despite the use of laxatives. The patient did not complain of any nausea, vomiting, or diarrhea. He had a significant medical history including diabetes, hypertension, prior coronary artery stenting, morbid obesity (with past gastric bypass surgery), longstanding ventral hernia, and back pain. A CT scan revealed multiple hernias and a potential closed-loop bowel obstruction, leading to a surgery consultation. Our client, an emergency general surgeon, interpreted that the patient did not have a closed loop or any significant obstruction and recommended non-surgical management. The patient was approved to have clear liquids, and had a vomiting incident shortly after, but our client was not notified. The patient was returned to NPO status, and after improving overnight, he was returned to “clears” and additional medical and renal consults were ordered. Our client did not receive any communications from the residents/nurses of any changes in the patient’s condition. On February 18, 2019, two rapid responses were called due to increased heart rate and vomiting. It is believed that the vomiting resulted in aspiration, causing sepsis, ultimately leading to the patient’s death. During the trial, the plaintiff’s sole medical expert highlighted imaging on the wrong hernia, which called into question all of his opinions in the case. We made key objections related to the expert testimony, limiting what the allegations were, and preventing new allegations from being made. After approximately two and a half hours of deliberating, the jury returned a no-cause verdict. 

News

Marshall Dennehey’s John J. Hare Brings Home Attorney of the Year Honors; Firm Named Litigation Department of the Year in Two Categories

Marshall Dennehey took home top honors in three categories at the The Legal Intelligencer’s 2026 Pennsylvania Legal Awards, held June 11 in Philadelphia. The first place awards include: Attorney of the Year: John J. Hare, Chair of the firm’s Appellate Advocacy & Post-Trial Practice Group and Executive Committee member, together with Charles “Chip” Becker of Kline & Specter Litigation Department of the Year, Appellate – Third Win in a Row! Litigation Department of the Year, Product Liability/Mass Torts “There is no one more deserving of Attorney of the Year honors than John. This award is a testament to his exceptional skill, dedication, and leadership—qualities that truly exemplify the very best of our firm,” said G. Mark Thompson, Marshall Dennehey’s President & CEO. “These honors also reflect the strength and depth of our product liability, mass torts, and appellate practices across Pennsylvania and beyond, underscoring our ongoing commitment to delivering outstanding results for our clients.” Attorney of the Year – John J. Hare, Marshall Dennehey, together with Charles “Chip” Becker, Kline & Specter Over the past year, John and Charles were opposing counsel in many of the highest-profile civil appeals in Pennsylvania. John is renowned as a preeminent appellate lawyer on the defense side, and Chip on the plaintiff's side. They have opposed each other repeatedly, exhibiting peerless professionalism and exceptional civility, while zealously litigating under the unremitting pressure of high-profile litigation and record-setting verdicts totaling more than $3.5 billion. They have also collaborated, outside of litigation, on many commissions, committees, and projects of importance to the Pennsylvania judiciary and legal community. Litigation Department of the Year – Appellate Law, Winner (previous winner, 2025 and 2024) 2025 was another standout year for the firm’s Appellate Advocacy & Post‑Trial Practice Group, led by John J. Hare, which was retained to challenge many of Pennsylvania’s “nuclear” verdicts—awards exceeding $10 million. Notably, the department persuaded the Pennsylvania Superior Court to reverse a Philadelphia judgment of $1.09 billion, the largest judgment ever overturned by a Pennsylvania appellate court. The group’s 11 full‑time Pennsylvania‑based appellate lawyers are at the center of Pennsylvania’s most high-profile matters, bringing more than 150 years of combined appellate experience. They routinely handle post‑trial and appellate matters and are frequently engaged to participate in and monitor trials in high‑exposure cases to ensure that critical legal issues are properly raised and preserved for appeal. Litigation Department of the Year – Product Liability/Mass Torts, Winner This marks the first win for the firm’s Pennsylvania Product Liability and Mass Torts practices, which operate within our Casualty Department, managed by Matthew Schorr and Jeff Rapattoni. For almost five decades, Fortune 500 product manufacturers/distributors and their insurers have turned to these groups to defend their litigation. Led by Bradley D. Remick and Vlada Tasich, our Product Liability group’s success can be attributed to its commitment to keeping abreast of ever-changing legal theories, judicial viewpoints, and evolving technology impacting the product liability landscape. Our attorneys have successfully handled thousands of product liability matters in all jurisdictions across the state. Likewise, our mass tort litigation practice – divided into Asbestos & Mass Tort, and Environmental & Toxic Tort Litigation –  has defended manufacturers, distributors, contractors, and premises owners in thousands of personal injury and other claims. Led by Kevin E. Hexstall and Patrick T. Reilly, most attorneys in these groups have more than 20 years of experience, and our seasoned trial team has tried hundreds of cases to verdict, consistently achieving strong results through both trials and settlements. In addition to these awards, Marshall Dennehey was a Litigation Department of the Year finalist for Professional Liability.

Thought Leadership

SIDEBAR: News and Happenings

We are pleased to share that attorneys from our health care team have been selected to the 2026  New Jersey and Pennsylvania Super Lawyers and Rising Stars lists. Their dedication to clients and commitment to high-quality work continues to strengthen our firm! Please join us in congratulating: NJ Super Lawyers: Robert T. Evers and Justin F. Johnson NJ Super Lawyer Rising Stars: Nataliana A. Guida  2026 Pennsylvania Super Lawyers: Alyson J. Kirleis and Gary M. Samms 2026 Pennsylvania Rising Stars: Holli K. Archer and Daniel Dolente Victoria Scanlon (Scranton) was a faculty presenter at the 2026 American Roentgen Ray Society (ARRS) Annual Meeting in Pittsburgh. She participated in the “Resident Symposium: Producing Quality Reports,” focusing her presentation on “How to Write a Great Report: Malpractice Lawyer’s Perspective.” Vicky, the only attorney presenter for this two-hour segment, was joined by several health care professionals including diagnostic radiologists, an interventional radiologist, an internal medicine physician, and a radiologist turned AI entrepreneur expert.  Matthew Keris (Scranton), President of the Pennsylvania Association for Health Care Risk Management (PAHCRM) and shareholder in our Scranton Health Care Department, presented an important and timely session titled “Keynote Address: A Conversation with RaDonda Vaught on Criminalizing Errors” at PAHCRM’s Annual Meeting in April. RaDonda is a former Tennessee nurse widely known for being criminally convicted in 2022 of negligent homicide and gross neglect after a 2017 fatal medication error at Vanderbilt University Medical Center. Her case gained national attention because she was criminally prosecuted rather than just facing licensing board action, sparking debate over blaming individual nurses for systemic healthcare failures. Matt and RaDonda’s conversation explored one of the most consequential issues in health care risk management today—how systems respond to human error, and what it means for patient safety, accountability, and the professionals who serve on the front lines. Gary Samms was a panelist for a podcast hosted by the Medical Liability Monitor, “From Outliers to Pattern: The Increasing Predictability of Megaverdicts in the Med-Mal Industry – and How to Reduce the Likelihood of Getting Hit with One.” Gary discussed the changing megaverdict landscape and why “outlier” verdicts are becoming structural, in addition to how plaintiffs turn weaknesses into megaverdicts (including building emotional narrative and jury psychology). Thank you to our clients who joined us for our Trends in Health Care & Health Law seminar on May 14. Led by our Health Care Department Director and Assistant Director, Robin Snyder and Donna Modestine, the session explored key issues that are currently shaping outcomes in health care litigation. We owe a debt of gratitude to our esteemed guest speaker, Mary Ellen Nepps, Esq., Senior Counsel, University of Pennsylvania, who presented “Medical Malpractice Litigation: Driving Another Health Care Crisis in Pennsylvania.” And special thanks to our attorneys who presented and shared their insights, including John J. Hare and Holli Archer who discussed “Highlights in PA Medical Malpractice Law;” David Drake for his presentation, “From Claims to Courtroom: Key Trends in NJ Medical Malpractice Litigation;” and Matthew Keris with an “Update on Health Care Tech Discovery.” Thank you to all of our clients for entrusting us with your health care litigation. We are proud to partner with you as we defend your interests and navigate legal landscapes together.